These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 2834573)

  • 21. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and efficacy of antiherpes type 1 and 2 subunit vaccines.
    Kavaklova L; Dundarov S; Andonov P; Bakalov B; Dundarova D; Brodvarova I
    Acta Virol; 1986 Sep; 30(5):402-10. PubMed ID: 2878588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subviral herpes simplex vaccine.
    Kutinovà L; Slichtová V; Vonka V
    Dev Biol Stand; 1982; 52():313-9. PubMed ID: 6299840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA regions and genes determining the virulence of herpes simplex virus.
    Rajcáni J
    Acta Virol; 1992 Mar; 36(2):208-22. PubMed ID: 1359774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective immunization of mice with specific HSV-1 glycoproteins.
    Chan WL
    Immunology; 1983 Jun; 49(2):343-52. PubMed ID: 6303950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic engineering and properties of novel herpes simplex viruses for use as potential vaccines and as vectors of foreign genes.
    Meignier B; Roizman B
    Adv Exp Med Biol; 1989; 257():187-92. PubMed ID: 2559609
    [No Abstract]   [Full Text] [Related]  

  • 28. Infection with herpes-simplex viruses 1 and 2. 1.
    Nahmias AJ; Roizman B
    N Engl J Med; 1973 Sep; 289(13):667-74. PubMed ID: 4353825
    [No Abstract]   [Full Text] [Related]  

  • 29. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. g. Infection defense antigens of paramyxoviruses].
    Kohama T
    Nihon Rinsho; 1987 Oct; 45(10):2263-8. PubMed ID: 3448265
    [No Abstract]   [Full Text] [Related]  

  • 30. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. l. Hepatitis B virus].
    Sugahara K
    Nihon Rinsho; 1987 Oct; 45(10):2292-7. PubMed ID: 3448268
    [No Abstract]   [Full Text] [Related]  

  • 31. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. o. Human immunodeficiency virus].
    Kurimura T
    Nihon Rinsho; 1987 Oct; 45(10):2312-5. PubMed ID: 3482287
    [No Abstract]   [Full Text] [Related]  

  • 32. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. n. Gene structure of HTLV and infection defense antigens].
    Maruyama T; Sugimoto M
    Nihon Rinsho; 1987 Oct; 45(10):2306-11. PubMed ID: 2896258
    [No Abstract]   [Full Text] [Related]  

  • 33. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. b. Herpes simplex virus].
    Kenichi U
    Nihon Rinsho; 1987 Oct; 45(10):2235-8. PubMed ID: 2834573
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetically engineered herpes simplex virus vaccines.
    Watson RJ; Enquist LW
    Prog Med Virol; 1985; 31():84-108. PubMed ID: 2982176
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.